Research on the oxidized dextran effect on fibrosis in the liver of rats with toxic hepatosis and liver cirrhosis
https://doi.org/10.18699/SSMJ20220105
Abstract
The aim of the study was to investigate the anti-fibrotic efficacy of oxidized dextran (OD) in post-toxic acute, chronic hepatosis and liver cirrhosis. Material and methods. 150 male Wistar rats weighing 280–320 g were injected intraperitoneally with 50 % CCl4 oil solution (1 ml/kg b.w.) and per os with 6.5 % aqueous solution of ethyl alcohol (40 ml per rat per day), as well as intraperitoneally – 2 ml of 5 % aqueous solution of oxidized dextran (OD) with a molecular weight of 40 kDa to the animal. The CCl4 solution has been injected once daily, the ethyl alcohol aqueous 6.5 % solution for 3 days. One group of rats has been injected with OD solution for 60 days till the first day after toxicants introduction. Another group has been administered with OD from the 30th days after the toxicants introduction to the 90th day. Toxicants were canceled on the 60th day. The third group of rats has been injected with toxicants for 60 days, and after toxicant cancel only OD has been injected for 30 days until the 90th day. The control group has been injected only with toxicants for 60 days, and there was still an “intact” control. Results and discussion. In animals that were injected with toxicants, and received OD from the 60th day, hepatocytes in a state of vacuolar degeneration and necrosis, microfibrosis were observed. But there was much more collagen in the periportal and interlobular zones. In addition, the so-called, false lobules from hepatocytes have been revealed in the period from 60 to 90 days after the introduction of toxicants. The OD introducing in treatment reduced the collagen content in the liver parenchyma as a whole, especially in the periportal zones, but most of all (up to 5 times) in the interlobular spaces as compared with animals that did not receive OD. This indicates a high antifibrotic efficacy of OD in acute, chronic hepatosis and cirrhosis of the liver.
About the Authors
M. A. Karpov
Federal Research Center of Fundamental and Translational Medicine; Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
Russian Federation
Mikhail A. Karpov, candidate of medical sciences
630117, Novosibirsk, Timakov str., 2
630091, Novosibirsk, Krasny ave., 52
V. D. Klochin
Federal Research Center of Fundamental and Translational Medicine
Russian Federation
Russian Federation
Vitalii D. Klochin
Novosibirsk, Timakov str., 2
V. A. Shkurupiy
Federal Research Center of Fundamental and Translational Medicine; Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
Russian Federation
Viacheslav A. Shkurupiy, professor, academician of the RAS
630117, Novosibirsk, Timakov str., 2
630091, Novosibirsk, Krasny ave., 52
References
1. Shkurupiy V.A., Kim L.B., Potapova O.V., Sharkova T.V., Putyatina A.N., Nikonova I.K. Study of fibrotic complications and hydroxyproline content in mouse liver at different stages of generalized BCG-induced granulomatosis. Bull. Exp. Biol. Med. 2014;157(4): 466–469.
2. Shkurupiy V.A. Tuberculous granulomatosis. Cytophysiology and address therapy. Moscow: RAMN, 2007. 536 p. [In Russian].
3. Shkurupiy V.A., Kim L.B., Kovner A.V., Cherdantseva L.A. Connective tissue and the problems of its pathological conditions. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2017;16(4):75– 85. [In Russian]. doi: 10.20538/1682-0363-2017-4-7585
4. Azzhargal B., Batbaatar G., Bira N. Comparative analysis of some laboratory parameters in alcoholic and viral hepatitis. Sibirskiy meditsinskiy zhurnal (Irkutsk) = Siberian Medical Journal (Irkutsk). 2013;118(3):38– [In Russian].
5. Shield K.D., Rylett M., Rehm J. Public health successes and missed opportunities: Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990–2014. Copenhagen: WHO/Europe, 2015. 88 p.
6. Buko V., Lukivskaja O., Belonovskaja E. Antifibrotic therapy of liver chronic disease. Nauka i innovatsii = Science and Innovation. 2013;130(12):56-60. [In Russian].
7. Shkurupiy V.A. Cytomorphological aspects of the pathogenesis of viral influenza and its nonspecific prophylaxis. Novosibirsk: Nauka, 2019. 257 p. [In Russian].
8. Karpov M.A., Shkurupy V.A., Troitskii A.V. The study of efficiency of the approach to prevent the adhesions in the abdominal cavity of rats. Bull. Exp. Biol. Med. 2021;171(4):416–420. doi: 10.47056/0365-96152021-171-4-418-423
9. Shkurupiy V.A., Potapova O.V., Sharkova T.V., Shestopalov A.M., Troitskii A.V. Effects of preventive administration of oxidized dextran on liver injury and reparative regeneration in mice infected with influenza A/H5N1 virus. Bull. Exp. Biol. Med. 2014;158(10):483– 488.
10. Volchek V.S., Sotnikova V.V., Kolesnikova K.I., Dohov O.V. The use of the toxic effect of carbon tetrachloride in the induction of experimental liver cirrhosis in rabbits and rats. Aktual’nyye nauchnyye issledovaniya v sovremennom mire = Actual Scientific Research in the Modern World. 2018;(11-6):124–128. [In Russian].
11. Skuratov A.G., Lyzikov A.N., Voropaev E.V., Achinovich S.L., Osipov B.B. Experimental modeling of toxic hepatic injury. Problemy zdorov’ya i ekologii = Health and Environment Issues. 2011;4(30):27–33. [In Russian].
12. Weibel E.L. Stereological methods. Practical methods for biological morphometry. London: Academic Press, 1979. 415 p.
13. Kordes C., Bock H., Reichert D., May P., Häussinger D. Hepatic stellate cells: current state and open questions. Biol. Chem. 2021;402(9):1021–1032. doi: 10.1515/hsz-2021-0180
14. Il’in D.A., Arkhipov S.A., Shkurupy V.A. Analysis of IL-1α, bFGF, TGF-β1, IFNγ, MMP-1, and CatD expression in multinuclea macrophages in vitro. Bull. Exp. Biol. Med. 2017;164(10):456–458.
15. Shkurupiy V.A., Troitskij A.V., Luzgina N.G. Method for producing dialdehyde dextran. Eurasian patent №011717 (№ 200801376) EAPO; published 28.04.2009.
Review
Views:
351
Email this article 